New York State Common Retirement Fund’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,338
Closed -$95K 3208
2024
Q4
$95K Hold
31,338
﹤0.01% 2617
2024
Q3
$163K Hold
31,338
﹤0.01% 2392
2024
Q2
$81K Buy
31,338
+62
+0.2% +$160 ﹤0.01% 2955
2024
Q1
$154K Sell
31,276
-4,264
-12% -$21K ﹤0.01% 2556
2023
Q4
$312K Buy
35,540
+1,857
+6% +$16.3K ﹤0.01% 2274
2023
Q3
$386K Buy
33,683
+229
+0.7% +$2.62K ﹤0.01% 2158
2023
Q2
$847K Sell
33,454
-9,036
-21% -$229K ﹤0.01% 1852
2023
Q1
$1.37M Sell
42,490
-10,118
-19% -$326K ﹤0.01% 1732
2022
Q4
$971K Buy
52,608
+2,010
+4% +$37.1K ﹤0.01% 1985
2022
Q3
$1.37M Buy
50,598
+111
+0.2% +$3K ﹤0.01% 1809
2022
Q2
$698K Sell
50,487
-135
-0.3% -$1.87K ﹤0.01% 2194
2022
Q1
$987K Buy
50,622
+23
+0% +$448 ﹤0.01% 2114
2021
Q4
$826K Sell
50,599
-135
-0.3% -$2.2K ﹤0.01% 2181
2021
Q3
$1.41M Sell
50,734
-10,084
-17% -$281K ﹤0.01% 1953
2021
Q2
$1.8M Buy
60,818
+3,718
+7% +$110K ﹤0.01% 1933
2021
Q1
$1.6M Hold
57,100
﹤0.01% 1910
2020
Q4
$1.62M Buy
57,100
+5,000
+10% +$142K ﹤0.01% 1791
2020
Q3
$1.31M Hold
52,100
﹤0.01% 1779
2020
Q2
$1.27M Buy
52,100
+8,200
+19% +$200K ﹤0.01% 1748
2020
Q1
$650K Buy
43,900
+4,400
+11% +$65.1K ﹤0.01% 1928
2019
Q4
$641K Sell
39,500
-7,600
-16% -$123K ﹤0.01% 2167
2019
Q3
$612K Hold
47,100
﹤0.01% 2223
2019
Q2
$611K Buy
47,100
+15,600
+50% +$202K ﹤0.01% 2265
2019
Q1
$496K Hold
31,500
﹤0.01% 2315
2018
Q4
$634K Sell
31,500
-5,000
-14% -$101K ﹤0.01% 2158
2018
Q3
$907K Hold
36,500
﹤0.01% 2147
2018
Q2
$1M Buy
36,500
+7,300
+25% +$200K ﹤0.01% 2098
2018
Q1
$899K Buy
29,200
+538
+2% +$16.6K ﹤0.01% 2083
2017
Q4
$1.03M Buy
28,662
+5,362
+23% +$192K ﹤0.01% 2016
2017
Q3
$642K Hold
23,300
﹤0.01% 2237
2017
Q2
$615K Sell
23,300
-1
-0% -$26 ﹤0.01% 2309
2017
Q1
$485K Buy
23,301
+4,401
+23% +$91.6K ﹤0.01% 2393
2016
Q4
$391K Hold
18,900
﹤0.01% 2478
2016
Q3
$306K Hold
18,900
﹤0.01% 2574
2016
Q2
$257K Hold
18,900
﹤0.01% 2607
2016
Q1
$330K Buy
18,900
+2,300
+14% +$40.2K ﹤0.01% 2443
2015
Q4
$567K Buy
16,600
+1,800
+12% +$61.5K ﹤0.01% 2252
2015
Q3
$440K Buy
14,800
+1,062
+8% +$31.6K ﹤0.01% 2370
2015
Q2
$439K Buy
+13,738
New +$439K ﹤0.01% 2570